Insulin signaling in health and disease
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms of cellular insulin action have been the focus of much investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in metabolic syndrome, a condition known as insulin resistance. The actions of the hormone are initiated by binding to its receptor on the surface of target cells. The receptor is an α2β2 heterodimer that binds to insulin with high affinity, resulting in the activation of its tyrosine kinase activity. Once activated, the receptor can phosphorylate a number of intracellular substrates that initiate discrete signaling pathways. The tyrosine phosphorylation of some substrates activates phosphatidylinositol-3-kinase (PI3K), which produces polyphosphoinositides that interact with protein kinases, leading to activation of the kinase Akt. Phosphorylation of Shc leads to activation of the Ras/MAP kinase pathway. Phosphorylation of SH2B2 and of Cbl initiates activation of G proteins such as TC10. Activation of Akt and other protein kinases produces phosphorylation of a variety of substrates, including transcription factors, GTPase-activating proteins, and other kinases that control key metabolic events. Among the cellular processes controlled by insulin are vesicle trafficking, activities of metabolic enzymes, transcriptional factors, and degradation of insulin itself. Together these complex processes are coordinated to ensure glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“Ser473 appears to be phosphorylated mainly by the rapamycin-insensitive mTOR complex mTORC2 (80).”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 7×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“The tyrosine residues phosphorylated in each substrate occur in specific sequence motifs; once phosphorylated, they serve as docking sites for intracellular molecules containing SH2 (Src homology 2) domains (1).”
BackgroundSelf-citationInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 6×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialCellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · cited 1×
“In part, variability may reflect the presence of three Akt isoforms (88).”
BackgroundDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 2×
“Hirosumi J, et al. A central role for JNK in obesity and insulin resistance.”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826 · cited 1×
“PI-(3,4,5)P3 recruits the serine/threonine kinase phosphoinositide-dependent kinase 1 (PDK1) to the plasma membrane through its PH domain and phosphorylates Thr308 on Akt (78, 79).”
BackgroundCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · cited 5×
“Other AGC kinases activated downstream of PI3K include the protein kinase C (PKC) family, particularly PKC-ζ.”
BackgroundInfluential
Research works printed but not linked: 4
- Kido, 2001, Clinical review 125: The insulin receptor and its cellular targets, J Clin Endocrinol Metab, 86, 972
- O-Sullivan, 2015, FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization, Nat Commun, 6
- 10.1172/JCI23096 · doi:10.1172/jci23096 · Paper page
- 10.1210/jcem.82.6.3979 · doi:10.1210/jcem.82.6.3979 · Paper page
Cited by
Items 301–400 of 448
The Multifaceted Actions of Polyphenols in the Management of Type-2 Diabetes MellitusPreprint
González, I., Lindner, C., Schneider, I., Díaz-Bautista, E., Morales, M. A., & Armando Rojas, R. (2023) · Preprints.org · doi:10.20944/preprints202307.0110.v1 · Cited by 2
Koh, D., Stratiievska, A., Jana, S., Otto, S. C., Swanson, T. M., Nhim, A., Carlson, S. G., Raza, M. M., Naves, L. A., Senning, E. N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.29.555449 · Cited by 2
A bioenergetic basis for multiorgan dysfunction in sepsisPreprint
Jentho, E., Ademolue, T. W., Sengers, H. P., Butler, J. M., Xu, L., Rastogi, S., Kitoko, J. Z., Pagnotta, S. E., Drotleff, B., Faísca, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.12.659280 · Cited by 2
Wisessaowapak, C., Weeraphan, C., Visitnonthachai, D., Chokchaichamnankit, D., Srisomsap, C., Watcharasit, P., Svasti, J., & Satayavivad, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14385 · Cited by 1
“It is well-documented that tyrosine phosphorylation of IRS promotes insulin sensitivity [10].”
BackgroundInfluentialFeatures of molecular mechanisms of insulin resistance pathogenesis in various tissues in obesity
Kuzmenko, D. I., Klimenteva, T. K., Самойлова, Ю. Г., Denisov, N. S., & Матвеева, М. В. (2023) · Obesity and metabolism · doi:10.14341/omet12839 · Cited by 1
Leow, S.-S., Khoo, J.-S., Ng, S.-M., Lee, W.-K., Hoh, C.-C., Fairus, S., Sambanthamurthi, R., & Hayes, K. C. (2023) · Genetica · doi:10.1007/s10709-023-00202-z · Cited by 1
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00001-2 · Cited by 1
Moqadam, S. M. R. S., Shokrzadeh, M., Sadeghimahalli, F., & Ghanbari, M. (2024) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2024-0011 · Cited by 2
Zarnaghi, M. R., Bahroudi, Z., Izadpanah, M., Seghinsara, A. M., & Abedelahi, A. (2024) · ImmunoAnalysis · doi:10.34172/ia.4055 · Cited by 1
Panchal, N., & Vaghela, V. M. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3339 · Cited by 2
Корнеева, Е. В., & Voevoda, M. I. (2025) · Ateroscleroz · doi:10.52727/2078-256x-2025-21-2-166-179 · Cited by 1
Zheng, W., Zhou, N., Kuang, J., Du, S., Zhu, D., Ling, R., Zhang, C., Wang, Y., Zhou, W., & Li, X. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110022 · Cited by 1
Upadhyay, S., Mazumder, A., & Das, S. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128382284250822045319 · Cited by 1
Exploring antidiabetic potential of plant diterpenes: from mechanisms to clinical insights
Anusri, E., Akhila, S., Augustine, S., & Pk, L. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03476-4 · Cited by 1
Drug-Induced Glucose Metabolism Disorders: Role of Aryl Hydrocarbon Receptor
Grishanova, A. Y., & Perepechaeva, M. L. (2025) · Journal of Xenobiotics · doi:10.3390/jox15060206 · Cited by 1
“[42,43].”
Zhang, Y., Liu, K., Fu, T., Zhang, Y., Xue, B., Wu, M. Y., Yang, D., & Chen, H. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.12.009 · Cited by 1
Homocysteine levels alter the TyG index-CKD link in Chinese hypertensive patients
Zhou, W., Yu, C. M., Bao, H., & Cheng, X. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04714-y · Cited by 1
Fiore, M., Saltarelli, S., Mastro, L. D., D’Ambrosio, E., Ianniello, A., Bertolino, A., Pergola, G., Favia, M., & Rampino, A. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110814 · Cited by 3
Fujimoto, T., Uchikawa, K., Akasaka, H., Yasunobe, Y., Yoshida, S., Onishi, Y., Minami, T., Asada, Y., Isaka, M., Sugimoto, K., et al. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70224 · Cited by 1
Role of neddylation in diabetes metabolism: potential therapeutic target
Li, H., Zeng, R., Liu, J., & Wang, H. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01837-9 · Cited by 1
Cuthbertson, D. J., Whyte, M., Henney, A. E., Alam, U., Goff, L. M., Fielding, B. A., & Umpleby, A. M. (2026) · Obesity Reviews · doi:10.1111/obr.70104 · Cited by 3
Luca, E., Shapiro, I., Debaix, H., Zitzmann, K., Wang, K., Auernhammer, C. J., Beuschlein, F., Nölting, S., & Hantel, C. (2026) · Biology Open · doi:10.1242/bio.062358 · Cited by 1
“For example, activation of the insulin/ PI3K/AKT pathway positively regulates not only cyclin D and CDK4/6, but Chk1 activity as well (Saltiel, 2021; Selvarajah et al., 2015).”
Small litter size attenuates adverse hepatic effects induced by a high-sucrose diet
Silva, J. L., de Deus, I. J., de Abreu, A. R. R., Fagundes, M. M. D. A., Breguez, G. S., Carneiro, C. M., Paula-Gomes, S., Costa, D. C., & de Queiroz, K. B. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110372 · Cited by 1
Zhu, Q., Liu, Q., Fan, Z., Shi, Y., Liu, X., Guo, Y., Luo, J., Zhao, J., Qin, W., Wang, Y., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.05.002 · Cited by 1
Pan, X., Chen, S., Li, Y., Wang, R., Gong, Y., Huang, X., Li, S., & Liu, N. (2026) · Fish Physiology and Biochemistry · doi:10.1007/s10695-026-01718-9 · Cited by 1
PFAS Exposure and Metabolic Disorders: Mechanistic Insights into Lipid and Glucose Homeostasis
Chen, X., Wen, W., Gu, S., Guo, F., Mo, Z., Chen, Z., Yan, S., & Wang, X. F. (2026) · Biomolecules · doi:10.3390/biom16071056 · Cited by 3
“Within insulin signaling, the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway serves as the central hub regulating glucose metabolism [150].”
Tunjung, W. A. S., Utomo, D. H., Patricia, A. B., Arfa, A. N., Kurniawan, C. Z., Maharani, A. (. E. P., Nurhidayat, L., Putri, W. A., Rosyadi, I., Saputra, W. D., et al. (2026) · Brazilian Journal of Biology · doi:10.1590/1519-6984.304124 · Cited by 1
Nagano, K., Suzuki, M., Morikawa, S., Watanabe, R., Ohara, T., & Hara, K. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag256 · Cited by 1
FETAL METABOLIC PROGRAMMING IN THE ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME
Silva, M. P. L. D., & Vargas, R. (2023) · Revista Contemporânea · doi:10.56083/rcv3n8-028 · Cited by 1
Endocrine Disorders Associated with Obesity
Park, H. K., & Ahima, R. S. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_42-2 · Cited by 1
GRg1 Ameliorates Insulin Resistance Through Activation of the PI3K/AKT/GSK-3β Pathway in HepG2 Cells
Shen, X., Jin, Y., Chen, Y., & Yang, H. (2023) · Pharmacognosy Magazine · doi:10.1177/09731296231198284 · Cited by 1
An Approach for Modeling and Analysis of Insulin Biosynthesis using Petri Nets
Guateque, M. L., de Miranda, A. B., Catanho, M., Hæusler, E. H., & Lifschitz, S. (2024) · IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) · doi:10.1109/cibcb58642.2024.10702168 · Cited by 1
Insulin Resistance and Its Biochemical Basis in Metabolic Syndrome
Hasnani, D., Iglesias-Fortes, S., Lockwood, Á. C., & Chavda, V. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-75686-3_2 · Cited by 3
Xiaoxu, F. A. N., Liu, J., Jian, H. U. A., Wang, Z., Shen, Y., Danyue, S. H. A. O., Zhenhui, J. I. N., & Jingxia, W. A. N. G. (2025) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2024.100489 · Cited by 1
Unlocking the Potential of Receptor-Based Approaches in Diabetes Treatment
Patwekar, M., Patwekar, F., Kumar, J. P., Prasad, P. D., Malik, N., Badarinath, A. V., Parupathi, P. R., Reddy, K. T. K., Elumalai, S., & Samad, Z. A. A. (2025) · BIO Integration · doi:10.15212/bioi-2024-0047 · Cited by 3
“Via translocation of the glucose transporter type 4 (GLUT4) to the cell membrane, Akt promotes glucose absorption in muscle and adipose tissues, and consequently modulates the metabolic effects of insulin [5–8].”
Liu, R., Liu, H., Li, R., Li, C., Xiao, H., & Chen, S. (2025) · Tropical Animal Health and Production · doi:10.1007/s11250-025-04357-z · Cited by 1
Chen, H.-J., Huang, M. N., Abuduwake, M., Mohammadtursun, N., & Yang, X. (2025) · Food, Nutrition and Health. · doi:10.1007/s44403-025-00034-z · Cited by 2
Hou, B.-W., Zheng, R., Li, Y., Zhang, J., Chu, Y., Gharaibeh, N. M., & Li, W. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i9.110183 · Cited by 1
Внутрішньоклітинні механізми дії гормонів. Сучасний погляд на проблему і перспективи
Tronko, M. D., Ковзун, О. І., PUSHKAREV, V. V., & Pushkarev, V. M. (2021) · Endokrynologia · doi:10.31793/1680-1466.2021.26-1.82 · Cited by 1
Targeting the insulin receptor with hormone and peptide dimers
Lin, J., Selicharová, I., Mitrová, K., Fabre, B., Miriyala, V. M., Lepšı́k, M., Jiráček, J., & Hernández, M. S. G. (2022) · Journal of Peptide Science · doi:10.1002/psc.3461 · Cited by 1
Az oxidatív stressz által kiváltott idült multihormonális rezisztenciák közös oka
Wittmann, I. (2023) · Diabetologia Hungarica · doi:10.24121/dh.2023.7
Koh, D., Stratiievska, A., Jana, S., Otto, S. C., Swanson, T. M., Nhim, A., Carlson, S. G., Raza, M. M., Naves, L. A., Senning, E. N., et al. (2024) · eLife · doi:10.7554/elife.91012.2 · Cited by 1
Cox, A. R., Masschelin, P. M., Saha, P., Felix, J. B., Sharp, R., Lian, Z., Xia, Y., Chernis, N., Bader, D. A., Kim, K. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.11.459899
Liu, M. A., Jati, S., Tang, K., van den Bogaart, G., Ghosh, G., & Mahata, S. K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.08.467835
MICRONUTRIENT DEFICIENCY IN THE PATHOGENESIS OF INSULIN RESISTANCE AND WAYS TO CORRECT IT
Mykytyuk, M. (2021) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2021.4.18
Eyme, K. M., Sammarco, A., Jha, R., Mnatsakanyan, H., Neustadt, R., Moses, C., Alnasser, A. A., Tardiff, D. F., Su, B., Williams, K. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.07.487530
Le récepteur de l’insuline a 50 ans – Revue des progrès accomplis
MEYTS, P. D. (2022) · Biologie Aujourd hui · doi:10.1051/jbio/2022007
Insulin Resistance and Type 2 Diabetes Mellitus Chain Reaction on Renal System
Sinha, S., & Haque, M. (2023) · Advances in Human Biology · doi:10.4103/aihb.aihb_4_23
Effectiveness of Myo- and d-chiro-inositol in the treatment of metabolic disorders
Diamanti‐Kandarakis, E., Papalou, O., & Soulage, C. O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91673-8.00005-4
Gu, L., Zhu, Y., Watari, K., Lee, M., Liu, J., Perez, S., Thai, M., Mayfield, J. E., Zhang, B., Rocha, K. C. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.05.531181
“Insulin is the master regulator of glucose homeostasis, keeping its blood concentration within a narrow range during fasting and feeding (Saltiel, 2021).”
BackgroundSelf-citationJørgensen, S. H., Emdal, K. B., Pedersen, A.-K., Axelsen, L. N., Kildegaard, H. F., Damozay, D., Pedersen, T. Å., Grønborg, M., Slaaby, R., Nielsen, P. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.14.571674
Tokuda, H., Hori, T., Mizutani, D., Hioki, T., Kojima, K., Onuma, T., Enomoto, Y., Doi, T., Matsushima‐Nishiwaki, R., Ogura, S., et al. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i2.302
Syndromes of severe insulin resistance: lessons from nature
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00005-x
Endocrine Disorders Associated with Obesity
Park, H. K., & Ahima, R. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_42
GLP-1 RECEPTORIŲ AGONISTŲ REIKŠMĖ 2 TIPO CUKRINIU DIABETU SERGANČIŲ PACIENČIŲ SVORIO MAŽINIMUI
Viliušytė, M., Maleckas, A., & Malinauskas, M. (2024) · Health Sciences · doi:10.35988/sm-hs.2024.021
Kinetic Modeling of Hepatic Metabolism and Simulation of Treatment Effects
Egners, A., Cramer, T., Wallach, I., & Berndt, N. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3694-7_16
Nahar, S. (2023) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc2257722
Karampelias, C., Băloiu, B., Rathkolb, B., da Silva‐Buttkus, P., Bachar-Wikström, E., Marschall, S., Fuchs, H., Gailus-Durner, V. X. E. R., Chu, L., de Angelis, M. H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.09.588677
“NO” controversy?: A controversial role in insulin signaling of diabetic encephalopathy
Chen, X., Song, Y., Hong, Y., Zhang, X. M., Li, Q., & Zhou, H. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112346
Isobavachromene ameliorates insulin resistance via inactivating the MAPK/NF-κB signaling pathway
Liu, Z., Liang, Z., Xu, L., Yuan, J., Li, Y., Kang, W., Zhang, Y., & Cong, B. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250369
陈, 梦. (2025) · Traditional Chinese Medicine · doi:10.12677/tcm.2025.141029
Literature Review on Proper and Safe Use of Insulin
Nijhu, R. S., & Saha, S. (2024) · Jabirian Journal of Biointerface Research in Pharmaceutics and Applied Chemistry · doi:10.55559/jjbrpac.v1i5.386
Astrocytic PI3Kα controls synaptic plasticity and cognitive function via serine metabolism
Fernández‐Rodrigo, A., Vilela, C. G., Eraso‐Pichot, A., Maroto, I. B., Moreno, M. D. G., López-Merino, E., Gutiérrez-Eisman, S., Sánchez‐Castillo, C., Boers-Escuder, C., Merino-Casamayor, E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77319-0
Shah, S. M. A., Khan, H. R., Afghan, T. S., Ahmed, N., Saeed, A., Ullah, M. N., Iftikhar, N., Gul, B., & Bibi, M. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i2.337
Yomakeshaiah, V. M., Prashantha, K., & Puttaswamy, N. Y. (2025) · Current Chemical Biology · doi:10.2174/0122127968376217250324190715
Chen, K., Feng, Q., & Liu, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-02518-y
Yarmolyuk, N. S., Джелдубаева, Э. Р., Степановна, Р. В., Tumanyanc, K., & Закировна, А. Д. (2025) · Scientific Notes of V I Vernadsky Crimean Federal University Biology Chemistry · doi:10.29039/2413-1725-2025-11-1-260-272
Luminescent insulin–Au( iii ) conjugate retains insulin biological properties in human microglia
Maysinger, D., Zhang, I., Yuan, H., Bonačić‐Koutecký, V., Maršić, Ž. S., & Antoine, R. (2025) · Nanoscale · doi:10.1039/d5nr01662b
Liu, H., Pan, Z., Yang, Q., Dai, L., Zhang, W., Zhang, Y., Liu, H., Li, Y., Zhong, K., Gu, J., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03122-1
Severe Insulin Resistance: Diagnosis and Management
Wu, Y., Wang, X., Zhang, W., Feng, D., & Luo, X. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998390048250902113845
Innovative nanotechnological approaches to diabetes treatment: the role of metal oxide nanoparticles
Shaban, E. E., & El-Aziz, M. E. A. (2025) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2025.2566460 · Cited by 1
Kirakosyan, A., Seymour, E., & Bolling, S. F. (2025) · Springer eBooks · doi:10.1007/978-3-031-96913-3_3
Quantitative modeling of insulin signaling reveals mechanisms of insulin resistance in obese mice
Morishita, S., Uda, S., & Kubota, H. (2026) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2026.111886
Chemical Interactions Involved in Insulin Receptor Activation: Scoping Review
Araujo, S. F. C., Costa, S. H. R., & de Araujo, A. S. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998373981250930135544 · Cited by 1
Omale, S., Aguiyi, J. C., Ede, S. O., Ryalls, L., Ye, R., Basbaydar, B., Gould, G. W., & Bremner, S. (2025) · PeerJ · doi:10.7717/peerj.20269
“Diabetes is a major health care issue around the globe ( Kahn, 2019 ; Saltiel, 2021 ).”
Insulin signaling in confluent diabetes and AD
Abraham, A., Gangadhara, V., & Baliga, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00008-8
Altered Molecular Regulation of TUG Is a Central Feature of Insulin-Resistant Human Adipose Tissue
Strober, J. W., ter Horst, K. W., Sung, D., Jongejan, A., Slusher, A. L., Gassaway, B. M., Tarabra, E., Paulo, J. A., Shuken, S. R., Gygi, S. P., et al. (2025) · Diabetes · doi:10.2337/db25-0488
Lonan, P., Munkong, N., Sangkham, S., Khonthun, C., Onsa-Ard, A., Nuntaboon, P., Chartarrayawadee, W., & Thim-uam, A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11353-x
Progressive muscle metabolic reprogramming in asymptomatic ALS gene mutation carriersPreprint
Buon, C., Milunov, D., Sapaly, D., Lenglet, T., Amador, M. D. M., Piller, E., Bendris, S., Cheguillaume, F., Slika, R., Siopi, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.15.694300 · Cited by 1
Du, R., Wu, N., Bai, Y., Tang, L., & Li, L. (2022) · Figshare · doi:10.6084/m9.figshare.19633785
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751152
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751137
Du, R., Wu, N., Bai, Y., Tang, L., & Li, L. (2022) · Figshare · doi:10.6084/m9.figshare.19633776
Du, R., Wu, N., Bai, Y., Tang, L., & Li, L. (2022) · Figshare · doi:10.6084/m9.figshare.19633779
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751140
Du, R., Wu, N., Bai, Y., Tang, L., & Li, L. (2022) · Figshare · doi:10.6084/m9.figshare.19633782
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751158
Wu, L., Wu, X., Hu, H., & 万启军 (2022) · Figshare · doi:10.6084/m9.figshare.21384365
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751155
Du, R., Wu, N., Bai, Y., Tang, L., & Li, L. (2022) · Figshare · doi:10.6084/m9.figshare.19633791
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751149
Achter, J. S., Vega, E. T., Sorrentino, A., Kahnert, K., Galsgaard, K. D., Hernández-Varas, P., Wierer, M., Holst, J. J., Wojtaszewski, J. F. P., Mills, R. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26751146
Du, R., Wu, N., Bai, Y., Tang, L., & Li, L. (2022) · Figshare · doi:10.6084/m9.figshare.19633788
Metadata
- Authors
- Saltiel, A. R.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Saltiel, Alan R.
- ORCID
- Saltiel, Alan R.
- Venue
- Journal of Clinical Investigation
- Published
- 2021-01-04
- Volume
- 131
- Issue
- 1
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7773347
- OpenAlex
- W3119743465
- Cited by
- 446
- References
- 210
- Citations by year
- 2026: 63 · 2025: 113 · 2024: 84 · 2023: 92 · 2022: 72 · 2021: 22
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124496, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin signaling, insulin resistance, metabolic syndrome, insulin receptor, tyrosine kinase, PI3K/Akt signaling, CBL, TC10, glucose homeostasis, vesicle trafficking, insulin degradation, transcription factors, GTPase-activating protein
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Receptor, Insulin, Phosphatidylinositol 3-Kinases, MAP Kinase Signaling System, Metabolic Syndrome, History, 20th Century, History, 21st Century, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.